ListedMainboardCONCORDBIO

Concord Biotech Limited

Concord Biotech Limited is a mainboard IPO raising ₹1,551 Cr at ₹705 – ₹741 a share. It listed on 18 Aug 2023 and trades at ₹1,255 today, +69.4% against its issue price of ₹741. It was subscribed 25× in total.

741
Issue price
1,255
Price now
+69.4%
Since issue price
18 Aug 2023
Listed on
25×Subscribed (final) · all exchanges

24.9 times more demand than shares on offer

populated partly populated we hold nothing here — the tab says why

Who bid for it

Investor categoryShares offeredShares bid forSubscribed
QIB
Banks, funds and other large institutions
41,83,13028,30,64,54068×
Foreign Institutional Investorsno separate quota12,30,55,580n/a
Domestic Financial Institutionsno separate quota10,02,31,820n/a
Mutual fundsno separate quota2,26,00,760n/a
Othersno separate quota3,71,76,380n/a
Non-institutional
Wealthy individuals and companies bidding above ₹2 lakh
31,37,3485,33,05,68017×
Non Institutional Investors20,91,5654,03,68,00019×
Corporatesno separate quota8,78,580n/a
Individualsno separate quota3,57,42,000n/a
Othersno separate quota37,47,420n/a
Non Institutional Investors10,45,7831,29,37,68012×
Corporatesno separate quota53,900n/a
Individualsno separate quota1,11,08,620n/a
Othersno separate quota17,75,160n/a
Retail
Ordinary investors bidding up to ₹2 lakh
73,20,4792,76,82,4803.78×
Cut Offno separate quota2,22,71,720n/a
Price bidsno separate quota54,10,760n/a
Employees10,0002,44,84024×
Cut Offno separate quota2,05,780n/a
Price Bidsno separate quota39,060n/a
Total1,46,50,95736,42,97,54025×

Sub-categories read no separate quota rather than a dash: the exchange publishes bids at that level but never a reservation against them, so a subscription multiple does not exist — it is not missing data. Bids across both exchanges (NSE and BSE) — the figure usually quoted publicly. Last updated 25 Jul, 07:14 pm IST.

How demand built

We hold no subscription readings for this issue.